Proton Pump Inhibitors in 2021: Pros, Cons, and Everything in Between

Joshua A. Sloan, Philip O. Katz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The medical and lay literature has exploded with reports of adverse events associated with proton pump inhibitors over the last 10 to 15 years. The dissemination of these reports to patients and clinicians have created substantial concerns regarding what has been an exceptionally valuable drug class, dramatically improving patient quality of life, and in many cases preventing life threatening side effects of other medication. Patients are more frequently seeking to avoid these medications, and practitioners are reducing or discontinuing them to the patient’s detriment due to a misunderstanding of the data. This review will discuss the data regarding the most commonly publicized adverse events and attempt to put them in perspective.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalForegut
Volume1
Issue number2
DOIs
StatePublished - Jun 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021.

Keywords

  • adverse outcomes
  • PPI
  • proton pump inhibitors
  • risks

Fingerprint

Dive into the research topics of 'Proton Pump Inhibitors in 2021: Pros, Cons, and Everything in Between'. Together they form a unique fingerprint.

Cite this